Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Maternal & Public Health Ave Maria Law Review

Analyzing the Impact of State Level Contraception Mandates on Public Health Outcomes

Abstract

The recent mandate by the U.S. Department of Health and Human Services requiring private health insurance plans to cover all FDA-approved contraceptive drugs has generated a considerable amount of controversy. Much of the commentary and analysis has discussed whether this mandate violates the conscience rights of religious employers; however, there has been considerably less discussion as to whether these contraception mandates offer any significant public health benefit. Since the late 1990s,
approximately thirty states have required that privately bought health insurance plans cover contraception. A time series cross-sectional analysis of state level public health data offers important insights as to what impact these contraceptive mandates have on public health outcomes. Results
indicate that state contraception mandates have little impact on either unintended pregnancy rates or abortion rates.

Read Complete Article

Latest Posts

April 29, 2026 A digital illustration of multiple blue cells with prominent nuclei floating in a blue background, representing a microscopic view of biological cells derived from human embryonic stem cells. Public Comment: Lozier Institute on NIH’s Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research April 14, 2026 An orange pill bottle, scattered white pills, and an ultrasound photo strip rest on a textured pink fabric surface, symbolizing the experience of a medical abortion. Drug-induced Abortion After the First Trimester April 10, 2026 White capsules spilling from an open white paper package onto a wooden surface, with several capsules scattered above the package—an image evoking the ongoing debate over America’s abortion law. Abortion Law in America Today: Confronting Infringements on Pro-life Laws

You Might Also Be Interested In

An orange pill bottle, scattered white pills, and an ultrasound photo strip rest on a textured pink fabric surface, symbolizing the experience of a medical abortion.

Drug-induced Abortion After the First Trimester

April 14, 2026
Please login to bookmark Close
Exterior of a Planned Parenthood building at 612, featuring a large blue logo and signage on a tan brick wall, with an arched entrance and hours sign visible below. Highlighted in the 2024-25 Annual Report for its welcoming design.

Fact Sheet: Planned Parenthood’s 2024-25 Annual Report

charlotte-lozier-institute Charlotte Lozier Institute
April 7, 2026
Please login to bookmark Close
A white pill bottle lies on its side, spilling round beige tablets onto a white surface. Behind it, several blurred ultrasound images hint at the risks and complications associated with drug-induced abortion in this clinical, medical scene.

Primer: Risks and Complications of Drug-Induced Abortion

April 6, 2026
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image